Mumbai, Feb. 27 -- The facility spans approximately 230,000 sq. ft. and has an installed capacity of 100 metric tons per year. This marks their second API manufacturing plant, significantly enhancing their existing API manufacturing capabilities.

Swapnil Shah, MD, SenoresPharmaceuticals, said, "We are delighted to commence operations at our Greenfield state-of-the-art API facility at Mehsana. Commissioning of this API facility will help Senores broaden its offerings and strengthen its competitiveness in the regulated markets, especially in the CDMO/CMO business."

Senores Pharmaceuticals (Senores) is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominan...